Skip to main content
. 2018 Mar 1;9:173. doi: 10.3389/fphar.2018.00173

FIGURE 3.

FIGURE 3

(A) Inhibition of T1551 on PRMT5 methyltransferase activity. (B) Protein expression levels of H4R3me2s in A549 cell treated with T1551 at different concentrations (0, 2.5, 5.0, and 10.0 μM). (C) Densitometric analysis of band intensities of H4R3me2s. Western blot analysis was performed for 24 h, with at least three independent experiments. Data was presented as mean ± SEM (n = 3), with ∗∗p < 0.01 for comparison between control group (DMSO-treated group) and T1551-treated group.